<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364470">
  <stage>Registered</stage>
  <submitdate>20/06/2013</submitdate>
  <approvaldate>15/07/2013</approvaldate>
  <actrnumber>ACTRN12613000789763</actrnumber>
  <trial_identification>
    <studytitle>Study on Adults and Iodine Deficiency (SAID)</studytitle>
    <scientifictitle>A randomised, double-blind, placebo-controlled intervention trial of the effect of iodine supplementation on thyroglobulin concentration in mildly iodine deficient young adults</scientifictitle>
    <utrn>U1111-1144-8095</utrn>
    <trialacronym>Study on Adults and Iodine Deficiency (SAID)</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Mild Iodine Deficiency</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral iodine supplement (150 mcg Iodine/day) for 6 months. Tablets will be supplied in a 28 day blister pack/month; blister packs will be returned and remaining tablets measured to monitor adherance.
</interventions>
    <comparator>Placebo supplement (0 mcg Iodine/day) for 6 months</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in serum thyroglobulin concentration measured by assay.</outcome>
      <timepoint>6 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in urinary iodine concentration</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy, free of thyroid disease, eats 2 or less servings of commercial bread/day, not taking iodine supplements, not pregnant or planning a pregnancy, not breastfeeding, with urinary iodine concentration less than 100 mcg/L.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Urinary Iodine Concentration &gt;100 mcg/L
Presence of thyroid antibodies 
Low T4 or High TSH</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Recruitment by advertisement.
Randomisation will be planned and generated by a researched not directly involved in participant recruitment or data collection. Allocation will be concealed by sealed opaque numbered envelopes.</concealment>
    <sequence>RAND on Excel in blocks stratified for sex</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Sample size was determined using STATA based on difference of 4 mcg/L at the end of the intervention between supplemented and placebo groups.
Regression Analysis, Mixed Models</statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>29/07/2013</anticipatedstartdate>
    <actualstartdate>15/07/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>9/07/2014</actualenddate>
    <samplesize>170</samplesize>
    <actualsamplesize>112</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Otago</primarysponsorname>
    <primarysponsoraddress>PO Box 56
Dunedin
9054
</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Laurenson Fund</fundingname>
      <fundingaddress>Otago Medical Research Foundation
Dept Physiology
University of Otago
PO Box 913
Dunedin 9054</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to determine the efficacy of thyroglobulin concentration in assessing iodine status in individuals.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Otago Ethics Committee</ethicname>
      <ethicaddress>Academic Services
University of Otago
PO Box 56
Dunedin
9054</ethicaddress>
      <ethicapprovaldate>19/03/2013</ethicapprovaldate>
      <hrec>13/059</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Sheila A Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin
9054</address>
      <phone>+643 479 7944</phone>
      <fax>+643 479 7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sheila A Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin
9054</address>
      <phone>+643 479 7944</phone>
      <fax>+643 479 7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sheila A Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin
9054</address>
      <phone>+643 479 7944</phone>
      <fax>+643 479 7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sheila A Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin</address>
      <phone>+643 479 7944</phone>
      <fax>+643 479 7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>